Insulin-Like Growth Factor-2 Binding Protein (IGF2BP3) is a Marker of Chromosomal Instability and Prognosis in Primary and Metastatic Non-small Cell Lung Carcinoma (NSCLC)

被引:0
|
作者
Mannan, Rahul [1 ]
Hosseini, Noshad [2 ]
Lih, Tung-Shing [3 ]
Mahapatra, Somnath [2 ]
Cho, Hanbyul [2 ]
Miller, Amanda [2 ]
Caldwell-Smith, Christine [2 ]
Cao, Xuhong [2 ]
Kumar-Sinha, Chandan [2 ]
Carr, Steven [4 ]
Mehra, Rohit [2 ]
Chinnaiyan, Arul [2 ]
Satpathy, Shankha [4 ]
Dhanasekaran, Saravana [2 ]
Gillette, Michael A. [4 ]
Nesvizhskii, Alexey [2 ]
Cieslik, Marcin [2 ]
Li, Qing Kay [5 ]
机构
[1] Univ Michigan, Michigan Med, Ann Arbor, MI USA
[2] Univ Michigan, Ann Arbor, MI USA
[3] Johns Hopkins Sch Med, Baltimore, MD USA
[4] Broad Inst MIT & Harvard, Cambridge, MA USA
[5] Johns Hopkins Univ Hosp, Baltimore, MD USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1553
引用
收藏
页码:S1933 / S1934
页数:2
相关论文
共 50 条
  • [1] Insulin-Like Growth Factor-2 mRNA Binding Protein 3 (IGF2BP3) Expression May Be a Marker for a Unfavorable Prognosis in Pancreatic Ductal Adenocarcinoma
    Schaeffer, D. F.
    Owen, D.
    Lim, H. J.
    Mehl, E.
    Buczkowski, A. K.
    Chung, S. W.
    Scudamore, C. H.
    Owen, D. A.
    Ng, S. S. W.
    Huntsman, D. G.
    MODERN PATHOLOGY, 2009, 22 : 321A - 321A
  • [2] Insulin-Like Growth Factor-2 mRNA Binding Protein 3 (IGF2BP3) Expression May Be a Marker for a Unfavorable Prognosis in Pancreatic Ductal Adenocarcinoma
    Schaeffer, D. F.
    Owen, D.
    Lim, H. J.
    Mehl, E.
    Buczkowski, A. K.
    Chung, S. W.
    Scudamore, C. H.
    Owen, D. A.
    Ng, S. S. W.
    Huntsman, D. G.
    LABORATORY INVESTIGATION, 2009, 89 : 321A - 321A
  • [3] Insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3) is a marker of unfavourable prognosis in colorectal cancer
    Lochhead, Paul
    Imamura, Yu
    Morikawa, Teppei
    Kuchiba, Aya
    Yamauchi, Mai
    Liao, Xiaoyun
    Qian, Zhi Rong
    Nishihara, Reiko
    Wu, Kana
    Meyerhardt, Jeffrey A.
    Fuchs, Charles S.
    Ogino, Shuji
    EUROPEAN JOURNAL OF CANCER, 2012, 48 (18) : 3405 - 3413
  • [4] THE ROLE OF INSULIN-LIKE GROWTH FACTOR 2 BINDING PROTEIN 3 (IGF2BP3) AS A DRIVER OF TUMORIGENESIS IN GLIOBLASTOMA
    Chow, Jocelyn
    Chen, Alexander
    Oh, Se-yeong
    Young, Elizabeth
    Boyd, Nathaniel
    Read, Renee
    NEURO-ONCOLOGY, 2023, 25
  • [5] Variation in Insulin-Like Growth Factor-2 Binding Protein 2 (IGF2BP2) is Associated With Declining Beta Cell Function
    Black, Mary Helen
    Watanabe, Richard M.
    Takayanagi, Miwa
    Trigo, Enrique
    Hartiala, Jaana
    Allayee, Hooman
    Lawrence, Jean M.
    Buchanan, Thomas A.
    Xiang, Anny H.
    DIABETES, 2012, 61 : A399 - A399
  • [6] Insulin growth factor-2 binding protein 3 (IGF2BP3) to promote lung tumorigenesis viaregulation of p53 stability.
    Zhao, Wei
    Lu, Dan
    Zhang, Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [7] Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) promotes lung tumorigenesis via attenuating p53 stability
    Zhao, Wei
    Lu, Dan
    Liu, Liang
    Cai, Juan
    Zhou, Yu
    Yang, Ying
    Zhang, Yu
    Zhang, Jun
    ONCOTARGET, 2017, 8 (55) : 93672 - 93687
  • [8] Insulin-like growth factor binding protein-3 inhibits the growth of non-small cell lung cancer
    Lee, HY
    Chun, KH
    Liu, BR
    Wiehle, SA
    Cristiano, RJ
    Hong, WK
    Cohen, P
    Kurie, JM
    CANCER RESEARCH, 2002, 62 (12) : 3530 - 3537
  • [9] INSULIN-LIKE GROWTH FACTOR 2 BINDING PROTEIN 3 (IGF2BP3/IMP3)-A NOVEL RNA BINDING PROTEIN WITH A ROLE IN GLIOMA DEVELOPMENT AND PROGRESSION
    Ramaswamy, Suvasini
    Somasundaram, Kumar
    Santosh, Vani
    Thota, Balaram
    Arivazhagan, A.
    NEURO-ONCOLOGY, 2009, 11 (05) : 569 - 569
  • [10] Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) overexpression in pancreatic ductal adenocarcinoma correlates with poor survival
    Schaeffer, David F.
    Owen, Daniel R.
    Lim, Howard J.
    Buczkowski, Andrew K.
    Chung, Stephen W.
    Scudamore, Charles H.
    Huntsman, David G.
    Ng, Sylvia S. W.
    Owen, David A.
    BMC CANCER, 2010, 10